发明名称 |
TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND DINACICLIB |
摘要 |
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and the CDK inhibitor dincaciclib, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1. |
申请公布号 |
EP3035964(A1) |
申请公布日期 |
2016.06.29 |
申请号 |
EP20140837218 |
申请日期 |
2014.08.15 |
申请人 |
MERCK SHARP & DOHME CORP. |
发明人 |
STRACK, PETER RICHARD;BOOHER, ROBERT;SRIRAM, VENKATARAMAN;PHILLIPS, JOSEPH, H. |
分类号 |
A61K39/395;A01N43/90;C07K14/475;C07K16/00 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|